← Open Payments lookup

STEPHEN STREITFELD: Open Payments

NPI 1306883293 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,172 in 48 payments from 12 companies in 2025. Trend: 2023 $924 · 2024 $1,061 · 2025 $1,172

Food & beverage: $1,172
CompanyPaymentsAmount
ABBVIE INC.13$272
Neurocrine BioSciences, Inc.6$211
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$168
Takeda Pharmaceuticals U.S.A., Inc.7$136
Teva Pharmaceuticals USA, Inc.4$121
Lundbeck LLC3$83
Janssen Pharmaceuticals, Inc2$58
E.R. Squibb & Sons, L.L.C.2$43
Almatica Pharma LLC1$31
Axsome Therapeutics, Inc.1$21

Products named: VRAYLAR, INGREZZA, CAPLYTA, TRINTELLIX, AUSTEDO XR, REXULTI, INVEGA SUSTENNA, COBENFY.

Industry payments across AZ — which companies pay providers there.